KANAZAWA UNIVERSITY
π―π΅Japan
- Country
- π―π΅Japan
- Ownership
- Private
- Established
- 1949-05-31
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.kanazawa-u.ac.jp
SGLT2 Inhibitor Versus Sulfonylurea on Type 2 Diabetes With NAFLD
Phase 4
Completed
- Conditions
- Non-alcoholic Fatty Liver Disease
- Interventions
- First Posted Date
- 2016-01-07
- Last Posted Date
- 2021-07-02
- Lead Sponsor
- Kanazawa University
- Target Recruit Count
- 40
- Registration Number
- NCT02649465
- Locations
- π―π΅
Kanazawa University Graduate School of Medical Sciences, Kanazawa, Ishikawa, Japan
Phase I of Vorinostat-Iressa Combined Therapy on Resistance by BIM Polymorphysim in EGFR Mutant Lung Cancer
- First Posted Date
- 2014-05-30
- Last Posted Date
- 2018-02-05
- Lead Sponsor
- Kanazawa University
- Target Recruit Count
- 12
- Registration Number
- NCT02151721
- Locations
- π―π΅
Tohoku University Hospital, Sendai, Miyagi, Japan
π―π΅Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan
π―π΅Shizuoka Cancer Center, Sunto-gun, Shizuoka, Japan
Clinical Trial of Autologous Adipose Tissue Derived Stromal Cell Therapy for Ischemic Heart Failure
Not Applicable
- Conditions
- Ischemic Heart Failure
- Interventions
- Biological: adipose tissue derived stromal cells dosage
- First Posted Date
- 2012-10-18
- Last Posted Date
- 2017-08-18
- Lead Sponsor
- Kanazawa University
- Target Recruit Count
- 6
- Registration Number
- NCT01709279
- Locations
- π―π΅
Kanazawa University Hospital, Kanazawa, Ishikawa, Japan
Efficacy and Safety of Ursodeoxycholic Acid (UDCA) Added to the DPP-4 Inhibitor in People With Type 2 Diabetes and Chronic Liver Diseases
Phase 4
- Conditions
- Type 2 Diabetes MellitusChronic Liver Disease
- Interventions
- First Posted Date
- 2011-04-18
- Last Posted Date
- 2011-04-18
- Lead Sponsor
- Kanazawa University
- Target Recruit Count
- 20
- Registration Number
- NCT01337440
- Locations
- π―π΅
Internal medicine, Kanazawa university hospital, Kanazawa, Ishikawa, Japan
Liver Regeneration Therapy by Intrahepatic Arterial Administration of Autologous Adipose Tissue Derived Stromal Cells
Not Applicable
Completed
- Conditions
- Liver Cirrhosis
- Interventions
- Biological: adipose tissue derived stromal cells dosage
- First Posted Date
- 2010-02-04
- Last Posted Date
- 2015-09-07
- Lead Sponsor
- Kanazawa University
- Target Recruit Count
- 4
- Registration Number
- NCT01062750
- Locations
- π―π΅
Kanazawa University Hospital, Kanazawa, Ishikawa, Japan
Liver Regeneration Therapy Using Autologous Adipose Tissue Derived Stromal Cells
Phase 1
Terminated
- Conditions
- Liver Cirrhosis
- Interventions
- Biological: adipose tissue derived stromal cells
- First Posted Date
- 2009-06-04
- Last Posted Date
- 2012-10-18
- Lead Sponsor
- Kanazawa University
- Target Recruit Count
- 6
- Registration Number
- NCT00913289
- Locations
- π―π΅
Kanazawa University Hospital, Kanazawa, Ishikawa, Japan
Β© Copyright 2025. All Rights Reserved by MedPath